#Safety / Adverse Event Signal Explorer

##Pharmacovigilance Analytics Dashboard (FAERS Q4-2024)

##Overview

This project presents an interactive pharmacovigilance dashboard built using FDA FAERS adverse event data to support drug safety signal detection, prioritization, and surveillance.

The dashboard integrates disproportionality metrics (PRR and ROR) with reporting volume to identify potential drugâ€“event safety signals while maintaining analytical transparency and regulatory-grade interpretability.

##Objectives

Detect potential adverse event safety signals using PRR and ROR

Prioritize high-risk drugâ€“event combinations

Visualize signal clustering and reporting patterns

Monitor quarterly reporting trends for surveillance context

##Key Features

-Top Adverse Events by Reports

-Top Drugs by Reports

-PRR vs ROR Signal Detection Scatter Plot

-High-Risk Safety Signal Review Table

-Signal Strength Heatmap (PRR intensity)

-Quarterly Reporting Trend (Q3â€“Q4 2024)

-Signal metrics are available for Q4-2024 only. Reporting trends include Q3â€“Q4 to provide surveillance context.

Dashboard Design Principles

Separation of exposure frequency and disproportionality signal strength

Transparent handling of temporal data availability

Interactive filtering by drug and adverse event

Interpretive annotations to prevent analytical misinterpretation

Tools Used

Tableau Public

FAERS adverse event datasets

Disproportionality signal metrics (PRR, ROR)

Live Dashboard

ðŸ‘‰ View on Tableau Public:
https://public.tableau.com/app/profile/tenekua.dugan

Analytical Focus

This project demonstrates real-world pharmacovigilance analytics, emphasizing:

Drug safety surveillance

Signal detection methodology

Healthcare data visualization

Regulatory-grade dashboard storytelling

Author

Tenekua Dugan
Healthcare & Scientific Analytics Portfolio
LinkedIn: www.linkedin.com/in/tenekuadugan
